Teleflex Incorporated has entered into a definitive agreement to acquire all the assets of LMA International for S$343.5m ($276m) in cash.

LMA manufactures airway management devices, including the Visualization and Atomization ranges, which are used in anesthesia and emergency care units.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Teleflex Incorporated chairman, president and CEO Benson Smith said the acquisitions will complement its current anesthesia and respiratory businesses, creating a stronger business with more than $530m in combined annual sales.

“The addition of these businesses significantly strengthens and expands our global anesthesia product portfolio, providing opportunities with respect to key clinical U.S. and international call points, while also further strengthening our GPO relationships,” Smith said.

The transaction, which is expected to be closed during the fourth quarter of 2012, is subject to LMA shareholder approval, regulatory approvals and other customary closing conditions.

In separate transaction, Teleflex also signed a definitive agreement with the shareholders of Intavent Direct and affiliates to acquire the LMA-branded laryngeal mask supraglottic airway business and certain other products in the UK, Ireland and Channel Islands.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Excluding non-recurring purchase accounting items and other acquisition and integration related costs, the transactions are expected to accretive Teleflex’s adjusted earnings per share by approximately $0.03 to $0.04 in fiscal year 2012 and $0.35 to $0.40 in fiscal year 2013.